Mereo BioPharma Group plc
MREO
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 53.02% | -22.37% | -36.93% | 1.73% | -39.49% |
| Total Depreciation and Amortization | -2.84% | 9.73% | -6.55% | -2.14% | -0.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -140.86% | 252.32% | 11.14% | -47.10% | 1,693.08% |
| Change in Net Operating Assets | 162.06% | -183.14% | 210.29% | 28.39% | -122.94% |
| Cash from Operations | -25.28% | 4.87% | 1.09% | -17.71% | -355.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 100.14% | -- | -- |
| Cash from Investing | -- | -100.00% | 100.14% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.27% | -171.23% | -- | -- | 100.00% |
| Cash from Financing | 93.27% | -101.27% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -204.65% | 1,225.23% | -52.86% | -104.16% | 267.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.16% | -117.82% | 542.54% | -71.52% | -153.42% |